.png)
Recent Research
YBTC fund world-class, innovative clinical research across Yorkshire. We want to find kinder treatment options for the people we support, and will continue to work tirelessly towards achieving improved health outcomes for all brain tumour patients.
Our latest research updates.
This project uses a specialised surgically-guided collection of brain tumour cells from different parts of the tumour to identify and investigate common weaknesses that we may be able to exploit with either existing or new therapies, with the hope to help fast track these into future clinical trials to help patients with this devastating disease.
Antonia Barry has been outstanding as evidenced by being first-author on a paper published - Lab on a chip (IF: 7.517) in May 2023: Barry A, et al. Investigating the effects of arginine methylation inhibitors on microdissected brain tumour biopsies maintained in a miniaturised perfusion system. Lab Chip. 2023 May 30;23(11):2664-2682. She has also investigated novel treatments for glioblastoma, the most severe type of brain tumours and a disease with no current cure, amongst many other achievements.
In Leeds, we continued to support the GlioModel which aims to overcome the difficulties in investigating brain tumour biology by building an experimental platform that will allow many types of test to be run in parallel. Assisted by our funding, they have now being able to make this competitive for large-scale funding.
The Leeds Neuropathology Research Tissue Bank went from strength to strength in 2023. Part-funded by Yorkshire's Brain Tumour Charity, applications to the tissue bank doubled in the past 12 months. The bank has supported, or is still supporting, 20 research projects aimed at understanding why brain tumours form; how we might find them earlier; and what we can do to reduce or stop the devastating effects they have.
